Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

3.3K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.3K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

5.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.4K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

27.2K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
27.2K
iPS Cell Differentiation01:22

iPS Cell Differentiation

3.0K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K
Embryonic Stem Cells00:57

Embryonic Stem Cells

4.7K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
4.7K
Chromatin Modification in iPS Cells01:32

Chromatin Modification in iPS Cells

2.1K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
2.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Predictors of 1-Year Mortality Among Patients With Heart Failure With Preserved Ejection Fraction.

JACC. Advances·2026
Same author

A long-term image-derived AI-based risk model for primary prevention of breast cancer in individuals at high risk.

Science translational medicine·2026
Same author

Factors that influence trust in non-standard stem cell therapies among patients with musculoskeletal conditions: a qualitative, constructivist grounded theory study.

Regenerative medicine·2026
Same author

Risk factors for acute pain after transvaginal ultrasound-guided oocyte retrieval: a retrospective study (2023-2024).

International journal of obstetric anesthesia·2026
Same author

Objective Real-Time Peripheral Regional Anesthesia Pressure Measurement in Children Using the CompuFlo Device, a Mono-Center Observational Study.

Paediatric anaesthesia·2026
Same author

Predictors of One-Year Mortality among Patients with Heart Failure with Preserved Ejection Fraction.

medRxiv : the preprint server for health sciences·2025
Same journal

Co-option of lysosomal machinery shapes the evolution of the intracellular photosymbiosis supporting coral reefs.

Cell·2026
Same journal

LEF1 and niche factors determine T cell stemness across chronic diseases.

Cell·2026
Same journal

Recurrent patterns of TOP1-mediated neuronal genomic damage shared by major neurodegenerative disorders.

Cell·2026
Same journal

Four-dimensional molecular mapping from a spatial snapshot reveals the dynamics of hair follicle organogenesis.

Cell·2026
Same journal

Whole-cell particle-based digital twin simulations from 4D lattice light-sheet microscopy data.

Cell·2026
Same journal

Systematic discovery of pathogen effector functions across human pathogens and pathways.

Cell·2026
查看所有相关文章

相关实验视频

Updated: Jan 10, 2026

Measuring the Confluence of iPSCs Using an Automated Imaging System
11:39

Measuring the Confluence of iPSCs Using an Automated Imaging System

Published on: June 10, 2020

2.4K

iPS 单元:绘制政策问题.

Amy Zarzeczny1, Christopher Scott, Insoo Hyun

  • 1Health Law Institute, University of Alberta, Edmonton, Alberta T6G 2H5, Canada.

Cell
|December 17, 2009
PubMed
概括
此摘要是机器生成的。

诱导多能干细胞 (iPS) 具有很大的前景,但它们的快速发展需要仔细考虑道德,法律和社会影响. 本综述考察了iPS细胞采购,研究和临床应用中的这些关键问题.

更多相关视频

Mapping the Emergent Spatial Organization of Mammalian Cells using Micropatterns and Quantitative Imaging
09:56

Mapping the Emergent Spatial Organization of Mammalian Cells using Micropatterns and Quantitative Imaging

Published on: April 30, 2019

7.0K
Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions
09:34

Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions

Published on: November 27, 2017

9.7K

相关实验视频

Last Updated: Jan 10, 2026

Measuring the Confluence of iPSCs Using an Automated Imaging System
11:39

Measuring the Confluence of iPSCs Using an Automated Imaging System

Published on: June 10, 2020

2.4K
Mapping the Emergent Spatial Organization of Mammalian Cells using Micropatterns and Quantitative Imaging
09:56

Mapping the Emergent Spatial Organization of Mammalian Cells using Micropatterns and Quantitative Imaging

Published on: April 30, 2019

7.0K
Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions
09:34

Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions

Published on: November 27, 2017

9.7K

科学领域:

  • 生物医学科学 生物医学科学
  • 干细胞生物学 干细胞生物学
  • 生物伦理学生物伦理学

背景情况:

  • 诱导多能干细胞 (iPS) 是从被重新编程到类似胚胎干细胞的体细胞中衍生出来的.
  • 该领域的iPS细胞研究经历了指数式增长,提出了重要的社会问题.
  • 伦理,法律和社会问题 (ELSI) 是iPS细胞技术负责任发展的组成部分.

研究的目的:

  • 综合审查围绕诱导多能干细胞 (iPS) 的伦理,法律和社会问题.
  • 为解决与采购iPS电池生成的原料相关的问题.
  • 检查iPS细胞研究及其转化到临床实践的含义.

主要方法:

  • 科学出版物的文献评论和伦理/法律分析.
  • 关键的伦理,法律和社会挑战的综合.
  • 基于iPS细胞生命周期的问题分类:采购,基础研究和临床翻译.

主要成果:

  • 采购用于iPS生成的电池引发了同意和所有权的问题.
  • 使用iPS细胞的基础研究涉及基因修饰和潜在的滥用.
  • 临床翻译面临与安全性,有效性,监管和公平获取相关的障碍.

结论:

  • 解决多方面的伦理,法律和社会问题对于负责地推进iPS细胞技术至关重要.
  • 与利益相关者积极参与是必要的,以应对iPS细胞研究和应用的复杂性.
  • 制定明确的指导方针和政策将促进iPS细胞疗法的伦理转化.